Bank of New York Mellon Corp - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 55 filers reported holding TALARIS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$58,136
-7.6%
20,6890.0%0.00%
Q2 2023$62,895
-42.9%
20,689
-64.7%
0.00%
Q1 2023$110,091
+84.3%
58,5590.0%0.00%
Q4 2022$59,731
-65.5%
58,559
-11.0%
0.00%
Q3 2022$173,000
-34.7%
65,806
+12.1%
0.00%
Q2 2022$265,000
-54.8%
58,694
-1.6%
0.00%
Q1 2022$586,000
-28.3%
59,622
+11.6%
0.00%
Q4 2021$817,000
+119.6%
53,424
+94.8%
0.00%
Q3 2021$372,000
+51.2%
27,422
+63.4%
0.00%
Q2 2021$246,00016,7790.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$8,240,62310.94%
BML Capital Management, LLC 2,000,000$5,620,0005.16%
Nantahala Capital Management 2,953,129$8,298,2920.71%
GREAT POINT PARTNERS LLC 1,000,000$2,810,0000.51%
Acuitas Investments, LLC 194,547$546,6770.32%
Affinity Asset Advisors, LLC 400,000$1,124,0000.32%
RA Capital Management 2,403,238$6,753,0990.13%
Artal Group S.A. 914,262$2,5690.11%
Blackstone Inc. 8,089,315$22,730,9750.10%
QVT Financial LP 589,314$1,655,9720.09%
View complete list of TALARIS THERAPEUTICS INC shareholders